Inhaled prostanoid therapy for pulmonary arterial hypertension – a promise unfulfilled?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.7, 2012-05, pp. : 923-925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-prostanoid prostacyclin agonists for the treatment of pulmonary arterial hypertension

By Antoniu Sabina A

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 327-330

Informa Healthcare

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Medical therapy for pulmonary arterial hypertension

By Driscoll James A Chakinala Murali M

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 1, 2008-01 ,pp. : 65-81

Informa Healthcare

Access to resources Recommend Favorite

Tadalafil: In Pulmonary Arterial Hypertension

By Croxtall Jamie D. Lyseng-Williamson Katherine A.

Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. : 479-488

Adis International

Access to resources Recommend Favorite

Terguride for pulmonary arterial hypertension

By Antoniu Sabina A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1333-1335

Informa Healthcare

Access to resources Recommend Favorite